Portal de Periódicos da CAPES

Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

2020; Springer Science+Business Media; Volume: 49; Issue: 3 Linguagem: Inglês

10.1007/s15010-020-01522-4

1439-0973

Valentina Marchese, Verena Crosato, Maurizio Gulletta, Filippo Castelnuovo, G Cristini, Alberto Matteelli, Francesco Castelli,

Dermatological diseases and infestations

SARS-CoV-2 pandemic has posed formidable public health and clinical challenges. The use of immunosuppressive agents, such as high dose corticosteroids and cytokine inhibitors (e.g., Tocilizumab) has been suggested to contrast the hyperinflammatory process involved in the pathogenesis of the severe disease, with conflicting evidence. Among the drawbacks of immunosuppressive therapy, the risk of reactivation of latent infections, including parasitic infestations, is to be considered.